NY-ANTENNA-GROUP
Antenna Group announced today the acquisition of Rubikon PR, a leading Czech public relations and marketing firm. This move marks a significant expansion of Antenna Group's European operations and reinforces its commitment to driving positive global change through innovative communication strategies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240904319818/en/
(Graphic: Business Wire)
Founded in 2012, Rubikon is known for its expertise in social impact, fintech, real estate, technology, and the industrial sector. By seamlessly integrating Rubikon into its global operations, Antenna is both expanding its global footprint and enhancing its ability to deliver creative, data-driven solutions at scale. This strategic integration will provide Rubikon's impressive client roster - including Too Good To Go, Freedom Finance, and SkyShowtime - with access to Antenna Group’s full-stack digital marketing, communications, and public affairs services, as well as its deep domain expertise, and award-winning creative talent.
The synergy created by this union is particularly timely given the Czech Republic's burgeoning climate tech sector. Consumer-friendly regulations in the Czech Republic have made it easier for homeowners to install rooftop solar, and the utility-scale solar industry is in its early stages of development. With a 236% increase in installed PV capacity in 2023, the Central and Eastern European (CEE) region and the European Union present exciting opportunities for sustainable growth and innovation.
"We are thrilled to welcome Rubikon into the Antenna Group family,” said Keith Zakheim, CEO of Antenna Group, “The acquisition is a significant milestone for Antenna as it further strengthens our ability to partner with global companies that are fostering innovation, driving sustainable growth across the planet and making a meaningful impact at scale. This union is not just an expansion of our geographical footprint; but, it amplifies our ability to craft impactful narratives that resonate across borders. This partnership embodies our commitment to fostering a more sustainable future through the power of storytelling, creativity, and technology. Together, we're poised to break new ground, connecting brands with audiences across borders and driving positive change in an increasingly interconnected world."
Šimon Rákosník, EVP of CEE Region, added, "Joining Antenna Group opens up a world of possibilities for our clients and our team. We're excited to combine our local insights with Antenna’s global expertise, particularly in areas like cleantech and sustainable technologies. Together, we're poised to create communication strategies that drive business success and contribute to solving some of the world's most pressing challenges."
This acquisition, following its recent expansion into London, underscores Antenna Group’s dedication to building a truly global, integrated network that can meet clients' evolving needs in an increasingly complex marketplace. By combining Rubikon's regional expertise with its worldwide resources, Antenna is building a powerhouse capable of delivering unparalleled value and driving positive change across North America, Europe, and beyond.
ABOUT ANTENNA GROUP
Antenna Group is a global integrated marketing and communications agency partnering with the world’s most exciting and disruptive companies across climate, energy, mobility, real estate, healthcare, and emerging B2B tech sectors. Our clients are transformational and distinguished corporations, startups, investors, and nonprofits at the bleeding edge of the Age of Adoption — the world today in which companies representing every economic sector are furiously adopting climate tech and sustainable solutions. To learn more, please visit antennagroup.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240904319818/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom